[1]
“PREVALENCE OF HEARING IMPAIRMENT AMONG HIGH RISK NEONATES ”, Journal of Pharmaceutical Negative Results, pp. 498–514, Dec. 2022, doi: 10.47750/pnr.2022.13.S02.72.